WallStreetZenWallStreetZen

NASDAQ: LUCD
Lucid Diagnostics Inc Stock Ownership - Who owns Lucid Diagnostics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lucid Diagnostics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis MatheisDirector2025-08-20100,000$1.02
$101.80kBuy
Dennis MatheisDirector2025-05-2233,218$1.32
$43.78kBuy
Dennis MatheisDirector2025-05-2233,218$1.32
$43.78kBuy
Dennis MatheisDirector2025-05-2233,218$1.32
$43.78kBuy
Dennis MatheisDirector2025-05-21129,684$1.32
$171.57kBuy
Dennis MatheisDirector2025-05-21129,684$1.32
$171.57kBuy
Dennis MatheisDirector2025-05-21129,684$1.32
$171.57kBuy
Dennis MatheisDirector2025-05-20187,098$1.30
$242.29kBuy
Dennis MatheisDirector2025-05-20187,098$1.30
$242.29kBuy
Dennis MatheisDirector2025-05-20187,098$1.30
$242.29kBuy

1 of 1

LUCD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LUCD insiders and whales buy or sell their stock.

LUCD Shareholders

What type of owners hold Lucid Diagnostics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pavmed Inc17.69%31,302,444$33.49MInsider
Vanguard Group Inc2.81%4,968,608$5.32MInstitution
Blackrock Inc2.44%4,312,638$4.61MInstitution
Masters Capital Management LLC2.26%4,000,000$4.28MInstitution
Lishan Aklog2.06%3,636,627$3.89MInsider
Aberdeen Group PLC1.95%3,457,894$3.70MInstitution
Two Seas Capital LP1.70%3,000,000$3.21MInstitution
Geode Capital Management LLC1.15%2,026,827$2.17MInstitution
Dennis M. McGrath1.02%1,813,569$1.94MInsider
Shaun Oneil0.82%1,446,763$1.55MInsider

1 of 3

LUCD vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LUCD18.19%24.12%Net Buying
INGN68.83%31.17%Net SellingNet Selling
ANIK81.51%18.49%Net SellingNet Selling
HYPR15.86%28.91%Net SellingNet Selling
CVRX41.08%58.92%Net BuyingNet Buying
View Top Medical Device Stocks

Lucid Diagnostics Stock Ownership FAQ

Who owns Lucid Diagnostics?

Lucid Diagnostics (NASDAQ: LUCD) is owned by 18.19% institutional shareholders, 24.12% Lucid Diagnostics insiders, and 57.69% retail investors. Pavmed Inc is the largest individual Lucid Diagnostics shareholder, owning 31.30M shares representing 17.69% of the company. Pavmed Inc's Lucid Diagnostics shares are currently valued at $34.12M.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.